It is widely reported that IL-17A and IL-17F polymorphic variants are correlated with increased susceptibility to several digestive system primary malignancies, such as gastric cancer [18], esophageal cancer [19], hepatocellular carcinoma [20, 21], and oral squamous cell carcinoma [22]. The gene discussed is IL17A; the disease is hepatocellular carcinoma.